Definition
Orphan drug designation is referenced in the context of Thymosin Alpha-1, which has orphan drug designation from the FDA. This designation is granted to drugs intended to treat rare diseases or conditions, and provides development incentives including tax credits and market exclusivity. Thymosin Alpha-1 is approved in over 30 countries for hepatitis B and C treatment.
Source: Thymosin Alpha-1 FAQ content
Related Peptides